Merck pays Moderna $250m for joint development of skin cancer vaccine
Moderna’s mRNA vaccine is being studied in combination with Merck’s Keytruda to treat patients with high-risk melanoma
Drugs
Pharma
Drugs
Medical
Pharma
Neumora Therapeutics raises $112 million in series B to fund neuro disorder research
Neumora Therapeutics raises $650 million to date to revolutionize treatment of brain diseases
Drugs
Pharma
Stalicla signs license deal for Evgens’ SFX-01
Evgen Pharma and Stalicla sign a $165 million licensing deal for neuro development disorder SFX-01 asset
Drugs
Pharma
Merck’s Covid-19 pill fails initial trial; AstraZenaca’s nasal spray too ineffective
Merck's Covid-19 pill no help in reducing hospitalization or death, Astrazenaca's nasal spray too fails trial
Pharma
Marksans Pharma to acquire Israel’s Tevapharm’s site in Goa
HQ team October 12, 2022: Marksans Pharma, a listed company, is set to acquire a manufacturing site of Tevapharm, an Indian subsidiary of.
Pharma
Cipla joins WEF’s ‘Lighthouse network’ to digitally transform operations
Cipla, an Indian pharmaceutical company, has joined the World Economic Forum’s Lighthouse network to adopt advanced fourth-industrial revolution technologies to transform operations digitally.
Pharma
Abu Dhabi’s Platinum Owl gets CCI nod to buy stake in Intas
HT team October 11, 2022: The Competition Commission of India, the country’s anti-trust regulator has given the nod for Platinum Owl to buy.
Drugs
Pharma
Israeli firm Teva Pharmaceuticals under EC scanner
The EC has intimated Teva Pharmaceutical Industries, an Israel-based global company, of its "preliminary view" that it has breached EU antitrust rules by.
Pharma
COVID-19 vaccine maker BioNTech inks research deal with Australia
COVID-19 vaccine maker BioNTech inks research deal with Australia
Drugs
Medical
Pharma
Speedier regulatory approval needed for antibiotics: Report
Rampant antibiotics resistance needs speedier regulatory approval for new drugs